Zobrazeno 1 - 10
of 310
pro vyhledávání: '"Neal, Bhatia"'
Autor:
Neal Bhatia, MD, Edward Lain, MD, Abel Jarell, MD, Janet DuBois, MD, Maria Luisa Tamarit, MD, Meritxell Falques, MSc, Vera Kiyasova, MD, PhD, Laura Padullés, PhD, Raquel Otero, PhD, Andrew Blauvelt, MD, MBA
Publikováno v:
JAAD International, Vol 17, Iss , Pp 6-14 (2024)
Background: Tirbanibulin is approved for actinic keratosis (AK) field treatment up to 25 cm2. However, AK often affects larger areas; thus, AK treatments for larger fields are needed. Objective: Evaluate the safety and tolerability of tirbanibulin wh
Externí odkaz:
https://doaj.org/article/028d807ef6364c51a40de0887761a442
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 8, Pp 2039-2058 (2024)
Abstract Skin cancer is the most common cancer type in the USA, with over five million annually treated cases and one in five Americans predicted to develop the disease by the age of 70. Skin cancer can be classified as melanoma or non-melanoma (NMSC
Externí odkaz:
https://doaj.org/article/1485b9caf5cb41549d6d4222a2b84c07
Autor:
Leon H. Kircik, Linda Stein Gold, Michael Gold, Jonathan S. Weiss, Julie C. Harper, James Q. Del Rosso, Christopher G. Bunick, Neal Bhatia, Emil A. Tanghetti, Lawrence F. Eichenfield, Hilary Baldwin, Zoe D. Draelos, Valerie D. Callender, George Han, Melinda J. Gooderham, Neil Sadick, Mary P. Lupo, Edward (Ted) Lain, William Philip Werschler
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1211-1227 (2024)
Abstract Introduction A three-pronged approach to acne treatment combining an antibiotic, antimicrobial, and retinoid may be more efficacious than single/double treatments while potentially reducing antibiotic resistance. This study evaluated the eff
Externí odkaz:
https://doaj.org/article/3acfbfb6dfc943fb93eb738feae1be47
Autor:
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro, J. Gabriel Vasquez
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 4, Pp 1019-1025 (2024)
Abstract Introduction Plaque psoriasis is a chronic condition that may impact patients’ work productivity. Tildrakizumab, an interleukin-23 p19 inhibitor, is approved for treatment of moderate-to-severe plaque psoriasis in adults. However, the effe
Externí odkaz:
https://doaj.org/article/dd57368cf9514d8484a62ba4c190ed77
Autor:
Neal Bhatia, Jayme Heim, J. Gabriel Vasquez, Tina Bhutani, Brad Schenkel, Ranga Gogineni, John Koo
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background Tildrakizumab is an anti-interleukin-23 p19 monoclonal antibody approved for the treatment of moderate-to-severe plaque psoriasis. This report describes final primary results of a 64-week real-world study of the effect of tildrakizumab on
Externí odkaz:
https://doaj.org/article/0940ec5a269642b98555403e0ba78955
Autor:
James Del Rosso, Hilary Baldwin, Neal Bhatia, Rajeev Chavda, Jean Phillipe York, Julie Harper, Firas George Hougeir, J. Mark Jackson, Omar Noor, David A. Rodriguez, Todd Schlesinger, Jonathan Weiss
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 2, Pp 271-284 (2024)
Abstract Rosacea is a common, chronic inflammatory disease characterized by both fluctuating and fixed heterogeneous signs such as facial erythema, papules/pustules, telangiectasia, acute vasodilation (flushing), and phymatous changes, and symptoms s
Externí odkaz:
https://doaj.org/article/a9f24466da95423798fe7cb430b39de5
Autor:
Zoe D. Draelos, Emil A. Tanghetti, Leon H. Kircik, Neal Bhatia, Joshua A. Zeichner, Jeffrey L. Sugarman, Linda Stein Gold
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Using a three-pronged acne treatment approach—combining an antibiotic, antimicrobial agent, and retinoid—may provide greater efficacy than monad or dyad treatments. Herein are the dermal sensitization, irritation, safety, and tolerabil
Externí odkaz:
https://doaj.org/article/3ec8e1d37444471991ac441ab74225fd
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Tildrakizumab is an anti–interleukin-23 p19 monoclonal antibody approved for the treatment of adults with moderate-to-severe plaque psoriasis. Little real-world evidence is available regarding the effects of tildrakizumab on patients’
Externí odkaz:
https://doaj.org/article/48d4a955160c43838e8c9c782436adba
Autor:
Neal Bhatia, MD
Publikováno v:
JAAD International, Vol 7, Iss , Pp 113-118 (2022)
Background: Since the introduction of imiquimod cream, patients have reported treatment-emergent symptoms that mimic influenza. However, clear relationships between the onset of symptoms from topical imiquimod and various variables (eg, patient’s a
Externí odkaz:
https://doaj.org/article/ede0d3043c654e4094cc40f77a09c947
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The objective of this work is to develop a fusion artificial intelligence (AI) model that combines patient electronic medical record (EMR) and physiological sensor data to accurately predict early risk of sepsis. The fusion AI model has two
Externí odkaz:
https://doaj.org/article/af6e6198c78f4e7294bfa5fc005711bf